Abstract:Introduction: The treatment strategy for elderly patients with acute myeloid leukemia (AML) is individualized due to the heterogeneity of the disease biology and the paucity of strong evidence in clinical practice. In general, regimens for elderly AML patients can be divided into standard intensive induction, low-intensity therapy, and best supportive care. Such medical decision-making regarding elderly patients with AML might be affected by physicians' occupational and non-occupational factors. Methods: We performed a national vignette-based survey of hematologists in China, to explore the impact of hematologists' personality and behavioral traits on medical decision-making for elderly AML patients. The medical decision-making for elderly AML patients was evaluated using 6 clinical vignettes. Hematologists' attitudes toward risk and uncertainty, personality traits, and decision-making styles were assessed using binary lottery choices and well-recognized self-report inventories. Results: Of the 820 eligible hematologists contacted, a total of 529 completed the survey; the response rate was 64.5%. In total, 354 (67%) were women. The mean age of the participants was 41.0 ± 7.4 years (range, 27-64 years). Senior hematologists accounted for 60% (n = 318) of the participants, including associate chief physicians (185, 35%) and chief physicians (133, 25%). The rest attending physicians, which are considered as junior hematologists, accounted for 40% of the participants (n = 211). The resulting binary regression model in predicting the therapy intensity preference of medical decision-making for elderly AML patients contained the following factors: hematologists' professional title group (OR = 0.012, 95% CI, 0.001 to 0.136, P < 0.001), conscientiousness (OR = 0.336, 95% CI, 0.121 to 0.932, P = 0.036), extraversion (OR = 0.403, 95% CI, 0.166 to 0.974, P = 0.044), conscientiousness by title group (OR = 2.009, 95% CI, 1.100 to 3.667, P = 0.023), and extraversion by title group (OR = 1.627, 95% CI, 0.965 to 2.743, P = 0.068). Using interaction analyses, we found that junior hematologists with a higher level of extraversion (mean difference = 0.27; 95% CI, 0.07 to 0.45; P = 0.009) or conscientiousness (mean difference = 0.19; 95% CI, 0.01 to 0.36; P = 0.028) tended to prescribe more intensive therapy. Meanwhile, no significant correlations between physicians' nonoccupational characteristics and medical decision-making for elderly AML patients were observed in senior hematologists. Conclusions: Our study suggests that hematologists' personalities contribute to medical decision-making for elderly AML patients, depending on the hematologists' professional titles. Among attending physicians, those with a higher level of extraversion or conscientiousness tended to prescribe more intensive therapy. Meanwhile, in chief and associate chief physicians, there was no significant correlation observed between hematologists' personality traits and medical decision-making for elderly AML patients. Disclosures No relevant conflicts of interest to declare.

Impact of Physicians’ Personalities and Behavioral Traits on Treatment-Related Decision-making for Elderly Acute Myeloid Leukemia

Impact of Hematologists' Personality and Behavioral Traits on Medical Decision-Making for Elderly Acute Myeloid Leukemia: A National Study in China

Factors Affecting Early Death and Survival of Patients with Acute Promyelocytic Leukemia Treated with ATRA-Based Therapy Regimens

The Difficulty of Medical Decision-Making: Should Patients Be Involved?

Aging and Comprehensive Molecular Profiling in Acute Myeloid Leukemia.

Clinical Characterization and Prognostic Factors of 144 Adult Acute Monocytic Leukemia

Treatment decision-making in acute myeloid leukemia: a qualitative study of older adults and community oncologists

Treatment Patterns and a Prognostic Scoring System for Elderly Acute Myeloid Leukemia Patients: a Retrospective Multicenter Cohort Study in China

Patient preferences, regret, and health-related quality of life among older adults with acute myeloid leukemia: A pilot longitudinal study

[Clinical Characteristics and Prognosis of 84 Elderly Patients with Acute Myeloid Leukemia].

Research Strategy for the Development of a Quality-of-Life Decision-Making Model for Older Patients With Acute Myeloid Leukemia

Decisional conflict, caregiver mastery, and depression among Chinese parental caregivers of children with leukemia

Behavioral Characteristics,Alexithymia and Coping Styles of Patients with Acute Leukemia

Non-intensive acute myeloid leukemia therapies for older patients

Therapeutic Effects of Low-Dose,ultra-low-dose and Standard-Dose Chemotherapy for Elderly Acute Myeloid Leukemia

Patient and Physician Decision Styles and Breast Cancer Chemotherapy Use in Older Women: Cancer and Leukemia Group B Protocol 369901

Economics Influences Therapy Decisions in Chronic Myeloid Leukaemia: Should It?

Analysis of Characteristics and Clinical Effectiveness of Acute Myeloid Leukemia in the Elderly

Prognostic analysis of non-cytogenetic factors in elderly adults with acute myeloid leukemia]

An Evil Backstage Manipulator: How Personality Traits Affect the Quality of Life and Clinical Outcome Evaluation in Patients with Crohn’s Disease

Evaluating a patient-centered discrete choice experiment to quantify individual treatment preferences of newly diagnosed older adults with acute myeloid leukemia: A mixed methods study.